skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I had the misfortune of investing in this company (hint: never take investing advice from a neighbour!) prior to the Cease Trade Order being issued. Is there any possibility that it will resume trading on the TSX at some point in the future. If not, can I sell my shares through my Canadian Webbroker account on the OTC Pink Sheets exchange?
Read Answer Asked by Chuck on February 11, 2021
Q: Hi,
Can you please let me know your opinion on this ? I know this has been beaten down and this may not fit in your investment style. However based on the cash in hand and net assets do you think it's trading less than it's book value , ignoring other factors such as law suits, possible re-instatement of the licence, etc. Thanks
Read Answer Asked by Dineth on December 30, 2019
Q: Taking a bit of a blood bath on Canntrust (-68%) and NVDA (-24%) watching Aurora Cannabis plummet and have some of that too. Get out now, buy or hold? Recommendations for alternatives with growth potential appreciated depending on your thoughts on the above 3.
Thanks.
Read Answer Asked by Wendy on July 15, 2019
Q: Hello Peter,
I like your response from the previous question on Canntrust but I would appreciate it if you can provide comments as to why this company which has been touted by analysts and BNN guests as one of the better players in the cannibis space, yet it has performed poorly when compared to most of the mid and large cap players. When you look at the chart from inception to now, Canntrust has not done well. Their fundamentals and strategy appear to be sound but why such a gap (comparing to weed, acb, cron, hexo, ogi, etc).
Also, on another note, KSHB, Kush holdings is bascially a picks and shovels play in the US for cannibis packaging etc and only trades over the counter (not on your list). It plans to list on nasdaq or nyse. If this happens, what would happen to my shares if they were bought over the counter. Would i be able to sell same shares on nyse or nasdaq. Apppreciate it.
Read Answer Asked by umedali on February 25, 2019
Q: Set to begin trading in New York on Feb 25th as of recent news. Had a nice bump yesterday. Can you give your thoughts on the following?
1. How does this stack up to bigger name producers in terms of value and potential? It is certainly less publicized
2. Looking back at other pot stocks that began trading in the US (2 i think?) what type of jump, if any, does the beginning of US trading have on prices?

Thanks!
Read Answer Asked by Tim on February 21, 2019
Q: Hello Peter,
With the cannabis stocks trading 50% below the legalization date, I would have thought any big companies that wanted to take an equity position in cannabis companies like Canntrust , Aphria, etc would have done it by now. Any thoughts on this? Also, I am starting to wonder if Knight is worth letting go now. This looks like a 30 year timeframe stock the way it is going... Appreciate the comments
Read Answer Asked by umedali on December 03, 2018
Q: Good day gentlemen,
I am attempting to differentiate between the largest Canadian producers on a valuation basis...specifically EV/EBITDA. As 2018 and 2019 will be ramp up years for most of these companies, Can you provide this estimated figure for years 2019 and 2020 for these companies and any others you may have in this sector.
Read Answer Asked by Giuseppe on November 21, 2018
Q: HI Peter
The numbers for the quarter were good from revenue but not profit, but the longer term numbers were good. Also, i would think for an emerging company, the revenues should be the focus, but I am assuming the market will bring it down like the rest of the cannibis stocks. What do you think of the numbers and do you think Canntrust looks good in comparison to others? Thanks
Read Answer Asked by umedali on November 15, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!